Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Venture Global on behalf of The Partnership for Safe Medicines
Lobbying Relationship
Bills mentioned
H.R.5663: Safeguarding Therapeutics Act
Sponsor: Brett Guthrie (R-Ky.)
S.3384: Lowering Prescription Drug Prices for America’s Seniors and Families Act...
Sponsor: Martha McSally (R-Ariz.)
H.RES.875: Expressing the sense of the House of Representatives that domain name...
Sponsor: Robert E. Latta (R-Ohio)
H.R.7002: Stop Coronavirus Scams Act
Sponsor: Bryan Steil (R-Wis.)
S.3148: Stopping Overdoses of Fentanyl Analogues Act
Sponsor: Ron Johnson (R-Wis.)
S.3201: Temporary Reauthorization and Study of the Emergency Scheduling of...
Sponsor: Lindsey Graham (R-S.C.)
S.4225: Safeguarding Therapeutics Act of 2020
Sponsor: Michael B. Enzi (R-Wyo.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Stephanie Burgess | LA, Matt Pacifico(PA); COS/OM, Rep. Beth Fukumoto, HI State Leg; Assi Cood, Missing Child Center-HI, Depart of the AG;LA,Cong Ted Poe; Ofc of State/Loc.Affairs, Ofc of Nat. Drug Control Policy, Executive Off of President; Intern Cong Ginny Brown |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate